Inventor · disambiguated record
Paulo Maciag
Also filed as: MACIAG PAULO · MACIAG PAULO C · MACIAG PAULO CESAR
14 granted patents·7 pending applications·198 citations·filing 2007–2022
94Inventor score
Top patents by PatentIndex Score
21 records- 0196US8771702B2Non-hemolytic LLO fusion proteins and methods of utilizing samePATERSON YVONNE·Filed 2008·Granted Jul 8, 2014·36 cites·17 claims
- 0295US9499602B2Non-hemolytic LLO fusion proteins and methods of utilizing sameUNIV PENNSYLVANIA·Filed 2014·Granted Nov 22, 2016·28 cites·19 claims
- 0394US9981024B2Compositions comprising angiogenic factors and methods of use thereofUNIV PENNSYLVANIA·Filed 2016·Granted May 29, 2018·7 cites·18 claims
- 0494US9919038B2Compositions comprising angiogenic factors and methods of use thereofUNIV PENNSYLVANIA·Filed 2016·Granted Mar 20, 2018·7 cites·16 claims
- 0593US8268326B2Compositions comprising HMW-MAA and fragments thereof, and methods of use thereofPATERSON YVONNE·Filed 2008·Granted Sep 18, 2012·16 cites·7 claims
- 0692US8241636B2Compositions comprising HMW-MAA and fragments thereof, and methods of use thereofPATERSON YVONNE·Filed 2007·Granted Aug 14, 2012·16 cites·9 claims
- 0790US9650639B2Dual delivery system for heterologous antigensADVAXIS INC·Filed 2014·Granted May 16, 2017·11 cites·18 claims
- 0890US9408898B2Compositions comprising angiogenic factors and methods of use thereofUNIV PENNSYLVANIA·Filed 2014·Granted Aug 9, 2016·10 cites·28 claims
- 0990US9017660B2Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumorsSHAHABI VAFA·Filed 2011·Granted Apr 28, 2015·22 cites·61 claims
- 1089US10189885B2Non-hemolytic LLO fusion proteins and methods of utilizing sameUNIV PENNSYLVANIA·Filed 2015·Granted Jan 29, 2019·6 cites·38 claims
- 1188US9644212B2Dual delivery system for heterologous antigensADVAXIS INC·Filed 2014·Granted May 9, 2017·11 cites·10 claims
- 1287US9084747B2Compositions and methods for prevention of escape mutation in the treatment of HER2/NEU over-expressing tumorsSHAHABI VAFA·Filed 2010·Granted Jul 21, 2015·16 cites·25 claims
- 1386US8778329B2Compositions comprising angiogenic factors and methods of use thereofSEAVEY MATTHEW·Filed 2010·Granted Jul 15, 2014·12 cites·15 claims
- 1471US10695410B2Compositions comprising angiogenic factors and methods of use thereofUNIV PENNSYLVANIA·Filed 2018·Granted Jun 30, 2020·0 cites·20 claims
- 1561US2015366955A9Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumorsADVAXIS INC·Filed 2014·Application pending·0 cites
- 1661US2024252487A1Methods of treating multiple myeloma using combination therapyCELGENE CORP·Filed 2022·Application pending·0 cites
- 1758US2011129499A1Dual delivery system for heterologous antigensMACIAG PAULO·Filed 2009·Application pending·0 cites
- 1857US2008124354A1Methods for administering tumor vaccinesPATERSON YVONNE·Filed 2007·Application pending·0 cites
- 1950US2015297702A1Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumorsADVAXIS INC·Filed 2015·Application pending·0 cites
- 2047US2016361401A1Compositions and methods for the treatment of her2/neu over-expressing tumorsADVAXIS INC·Filed 2015·Application pending·0 cites
- 2142US2007264279A1Compositions and methods comprising a MAGE-b antigenGRAVEKAMP CLAUDIA·Filed 2007·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →